PALM BEACH GARDENS, Fla. — AccuDial Pharmaceutical on Thursday announced its Children's AccuDial line of pediatric medications featuring the company’s accurate weight-based dosing label has been awarded the PTPA Winner’s Seal of Approval.
“Winning the PTPA Winner’s Seal of Approval is both humbling and exciting for AccuDial Pharmaceutical,” AccuDial chairman and CEO Robert Terwilliger said. “We found that by leveraging innovative technology, AccuDial’s labeling system is able to meet both a functional and emotional need in consumers that resonates in the market.”
PTPA Media consists of North America’s largest volunteer parent testing community, with more than 40,000 parents. Because independent parent volunteers evaluate these products in their own homes, PTPA winners are chosen based on merit and consumer experience — not on commercial considerations, the company stated.
“At PTPA Media, we are proud to play a role in certifying innovative products that families can trust,” PTPA Media CEO Sharon Vinderine said. “When consumers search for our Seal of Approval on product packaging and websites, they are essentially searching for validation from their peers. Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless.”
AccuDial also announced the company will soon launch Children’s Pain and Fever with acetaminophen in five flavors: cherry, dye-free cherry, bubblegum, strawberry and grape.